인쇄하기
취소

Despite MERS sales of listed pharmaceutical companies increased 10% up in the 2nd quarter

Published: 2015-08-19 13:49:03
Updated: 2015-08-19 13:49:03

Despite the Middle East Respiratory Syndrome, which struck Korea in the 2nd quarter of the year, sales of listed pharmaceutical companies are assessed to be decent.

According to the analysis result of sales reports of 58 KOSPI and KOSDAQ listed pharmaceutical companies in the 2nd quarter of the year, conducted by YakupDotCom(www.yakup.com), their sales were observed to increase 14.6% compared ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.